NAD+ is administered as a subcutaneous injection at Perfect B, using a protocol of 5 injections per week for up to 6 weeks
Sloop KW, Cox AL, Wainscott DB, White A, Droz BA, Stutsman C, Showalter AD, Suter TM, Dunbar JD, Snider BM, OFarrell LS, Hewitt N, Ruble JC, Padgett LR, Woerly EM, Peterson JA, Coskun T, Liu Z, Coutant DE, Ai M, Emmerson PJ, Sangwung P, Willard FS (2024) The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
The burping and eructation side effects vary by formulation and dose
Jardiance Although not available yet in the United States, an oral form of Ozempic is available in Europe
These peptides complement IGF-1 LR3's anabolic effects by supporting the connective tissue and recovery infrastructure that intense training demands